ArticleScientific reports2026
Dietary gallic acid facilitate growth performance, improve slaughter performance through enhanced intestinal function in yellow-feathered broiler.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regarding the antibacterial and antioxidant properties of Gallic acid (GA), it was used as feed additive to evaluate intestinal health and production performance of broilers. Yellow-feathered male broilers (375 birds at 21-day-old) with similar body weight were randomly divided into five groups, each with five replicates and 15 chickens per replicate. Chickens were fed basal diet with 0, 50, 100, 150, and 200 mg/kg GA for 42 days. Then, chickens were slaughtered for slaughter performance, intestinal function, gut microbiota measurement. Compared to the control group, supplementation with 150 mg/kg GA significantly increased body weight at 42, 56, and 63 days of age (P < 0.05), significantly increased average daily gain (ADG) and reduced feed conversion ratio (FCR) during the growth phase (P < 0.05), and increased abundances of Firmicutes and decreased abundances of Bacteroidetes (P < 0.05). Supplementation with both 100 and 150 mg/kg GA significantly decreased abdominal fat rate and increased breast muscle rate (P < 0.05), and enhanced expression of IL-1β, TNF-a, TLR4, HSP70, mucin2 and Nrf2 (P < 0.05). In conclusion, GA (150 mg/kg) was associated with improved growth and slaughter performance and with changes in intestinal gene expression and cecal microbiota compositions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.